Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

night2. The same periodicity was observed in the onset of stroke. Striking evidence suggests that the morning surge in blood pressure is crucial in determining the rupture of critically weakened arterial walls and subjects with a large surge in morning blood pressure have a significantly elevated risk of intracerebral hemorrhage3 and stroke4.

Current hypertension therapy therefore aims at a full 24-hour blood pressure control. Commonly used angiotensin II receptor blockers (ARBs) were reported to achieve an ambulatory blood pressure reduction from baseline in the early morning hours of (SBP / DPB) - 8.7 / - 5.8 mm Hg (valsartan) and - 11.0 / - 7.6 mmHg (telmisartan), respectively5.

About hypertension
Hypertension, also termed high blood pressure, is a medical condition where the blood pressure is chronically elevated. Although asymptomatic in nature and in itself rarely an acute problem, persistent hypertension is one of the most important preventable causes of premature death worldwide and contributes to around half of all cardiovascular disease6. It is one of the major risk factors for stroke, myocardial infarction, heart failure, and arterial aneurysm, and is a leading cause of chronic renal failure. Genetic predisposition and lifestyle habits such as inadequate physical activity, high fat diet, and high salt intake promote high blood pressure. Up to 30% of adults in
most countries suffer from hypertension6. Despite effective and relatively inexpensive treatment available, a health survey in the UK revealed that only 9% of hypertensive individuals have their blood pressure controlled successfully7. This poor overall treatment success is mainly attributed to the asymptomatic nature of hypertension and the necessity for long-term treatment with medications that require at least once daily self-administration.

About CYT006-AngQb
CYT006-AngQb is a therapeutic vaccine in development for treatment of hypertensio
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:11/26/2014)... 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that ... approximately $3.3 million at a price of $0.30 per ... focused investor. Each unit consists of one common share ... warrant. Each whole warrant entitles the holder to acquire ... a period of five years from closing.  ...
(Date:11/26/2014)... Texas , Nov. 26, 2014 ... today announced the completion of previously announced concurrent ... million.  After fees and estimated offering expenses, Lexicon ... the transactions.  The transactions consisted of: ... common stock, pursuant to a registration statement that ...
(Date:11/26/2014)... -- Investor-Edge has initiated coverage on the following ... PLC (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... ), and Theravance Inc. (NASDAQ: THRX ). Free ... http://investor-edge.com/register . On Tuesday, November 25, 2014, the ... Industrial Average edged 0.02% lower, to finish the day at ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
(Date:11/28/2014)... 28, 2014 Dr. Andrew Campbell, one ... announced the expansion of Quintessa Aesthetic Center into a ... located at W307 N1497 Golf Road in Suite 200 ... Dr. Campbell, the new Delafield location will offer a ... patients, including: Botox, filler injectables , micro laser ...
(Date:11/28/2014)... 2014 The Alternative Health ... the past five years. The industry has been ... that are either alternative to conventional Western medicine ... industry analyst David Whytcross, “industry revenue has been ... private health insurance membership.” Meanwhile, improving economic conditions ...
(Date:11/28/2014)... News) -- Planning on seconds at Thanksgiving Day dinner ... known as gastroesophageal reflux disease (GERD) -- a few steps ... ear, nose and throat specialist at Lenox Hill Hospital in ... GERD on Thanksgiving: Pace yourself. Rather ... meals throughout the day. It,s also a good idea to ...
(Date:11/28/2014)... 28, 2014 An inventor and dental assistant ... a patient’s filling and it was almost impossible to reach. ... light," she said. , The patent-pending Access Light allows for ... to areas of the mouth, as well as avoids harm ... safety. Easy to use and clean, it also helps prevent ...
(Date:11/28/2014)... 2014 A newly released article ... of the influenza virus that will soon be spreading across ... The article begins with a brief explanation of what the ... reminds families that children under the age of 5, adults ... diseases, such as heart and lung diseases, asthma, or diabetes, ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
... increase in Social Security Disability Insurance recipients; time-intensive process of receiving ... Allsup , ... Belleville, Ill. (Vocus) June 25, 2008 ... Insurance (SSDI) benefits continued to grow in 2007. This means ...
... The National Intelligence Council (NIC) has completed a new ... U.S. security in the next 20 years by causing ... over water and other resources in specific countries. The ... June 25, on the main findings. , ...
... are the workhorses of our cells. They help to digest ... and literally shape our body from top to toe. Proteins ... of enzymes, which are important in the creation of anything ... possibilities are virtually without limit. , To take advantage ...
... of venous thromboembolism, study finds , , WEDNESDAY, June 25 ... rivaroxaban helps prevent potentially fatal blood clots after hip ... of venous thromboembolism (VTE) is high after total hip ... leaves hospital. Current guidelines recommend patients receive a heparin-based ...
... Pharmavite, a leader in the,dietary ... consumer-centric,program, LearnSomethingAbout(TM), as a partner in ... consumer-oriented multimedia,program that seamlessly integrates into ... "LearnSomething shares similar goals with Pharmavite ...
... MedeFile,International, Inc. (OTC Bulletin Board: MDFI), a company ... announced,that a highly exclusive, membership only, resort community ... memberships and is offering,MedeFile,s full suite of products ... 1,400 members., Members who subscribe to MedeFile,s ...
Cached Medicine News:Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Climate change may challenge national security, classified report warns 2Health News:Climate change may challenge national security, classified report warns 3Health News:1 step closer to green chemistry and improved pharmaceuticals 2Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere 2
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
... The Attain™ Deflectable Catheter - designed ... using a single catheter. Steerablility - Create ... procedure with a single, steerable guide catheter. ... desired shape to address each patient's unique ...
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity....
... The Hancock® II bioprosthesis from ... years of proven clinical experience. ... the freedom from structural valve ... and mitral bioprostheses is substantially ...
Medicine Products: